Treatment of antineutrophil cytoplasm autoantibody-associated systemic vasculitis: initiatives of the European Community Systemic Vasculitis Clinical Trials Study Group. by Jayne, DR, Rasmussen, N

Anti-glomerular basement membrane disease after alemtuzumab. by Clatworthy, MR, Wallin, E, Jayne, DR

More on Anti-Glomerular Basement Membrane Disease after Alemtuzumab Reply by Clatworthy, MR, Wallin, E, Jayne, DR

The authors reply by Clatworthy, MR, Wallin, E, Jayne, DR

Assessment of damage in vasculitis: Expert ratings of damage by Seo, P, Jayne, DR, Luqmani, R, Merkel, P

Should rituximab be used to treat antineutrophil cytoplasmic antibody associated vasculitis? by Flossmann, O, Jones, R, Jayne, DR, Luqmani, R

The role of biologic therapies in the management of systemic vasculitis. by Chan, A, Flossmann, O, Mukhtyar, C, Jayne, DR, Luqmani, R

Health-related quality of life in patients with newly diagnosed antineutrophil cytoplasmic antibody-associated vasculitis. by Walsh, M, Mukhtyar, C, Mahr, A, Herlyn, K, Luqmani, R, Merkel, P, Jayne, DR

Intravenous immunoglobulin for ANCA-associated systemic vasculitis with persistent disease activity. by Jayne, DR, Chapel, H, Adu, D, Misbah, S, O'Donoghue, D, Scott, D, Lockwood, C

Infliximab improves endothelial dysfunction in systemic vasculitis: a model of vascular inflammation. by Booth, A, Jayne, DR, Kharbanda, R, McEniery, C, Mackenzie, I, Brown, J, Wilkinson, I

Human T-follicular helper and T-follicular regulatory cell maintenance is independent of germinal centers. by Wallin, E, Jolly, E, Suchánek, O, Bradley, J, Espéli, M, Jayne, DR, Linterman, M, Smith, K

Peripheral neuropathy in ANCA-associated vasculitis: outcomes from the European Vasculitis Study Group trials. by Suppiah, R, Hadden, R, Batra, R, Arden, N, Collins, M, Guillevin, L, Jayne, DR, Luqmani, R

Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis. by De Groot, K, Rasmussen, N, Bacon, P, Tervaert, J, Feighery, C, Gregorini, G, Gross, W, Luqmani, R, Jayne, DR

Randomized trial of cyclophosphamide versus methotrexate for induction of remission in "non-renal" AbCA-associated vasculitis. by de Groot, K, Rasmussen, N, Bacon, P, Tervaert, J, Feighery, C, Gregorini, G, Gross, W, Luqmani, R, Jayne, DR, Grp, E

Deoxyspergualin in relapsing and refractory Wegener's granulomatosis. by Flossmann, O, Baslund, B, Bruchfeld, A, Tervaert, J, Hall, C, Heinzel, P, Hellmich, B, Luqmani, R, Nemoto, K, Tesar, V, Jayne, DR

Comparison of disease activity measures for anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis. by Merkel, P, Cuthbertson, D, Hellmich, B, Hoffman, G, Jayne, DR, Kallenberg, C, Krischer, J, Luqmani, R, Mahr, A, Matteson, E, Specks, U, Stone, J

Recommendations for the use of rituximab in anti-neutrophil cytoplasm antibody-associated vasculitis. by Guerry, M, Brogan, P, Bruce, I, D'Cruz, D, Harper, L, Luqmani, R, Pusey, C, Salama, A, Scott, D, Savage, C, Watts, R, Jayne, DR

Granulomatosis with polyangiitis (Wegener's): an alternative name for Wegener's granulomatosis. by Falk, R, Gross, W, Guillevin, L, Hoffman, G, Jayne, DR, Jennette, J, Kallenberg, C, Luqmani, R, Mahr, A, Matteson, E, Merkel, P, Specks, U, Watts, R

Reply. by Falk, R, Jennette, J, Gross, W, Guillevin, L, Hoffman, G, Jayne, DR, Kallenberg, C, Luqmani, R, Mahr, A, Matteson, E, Specks, U, Merkel, P, Watts, R

Granulomatosis with polyangiitis (Wegener's): an alternative name for Wegener's granulomatosis. by Falk, R, Gross, W, Guillevin, L, Hoffman, G, Jayne, DR, Jennette, J, Kallenberg, C, Luqmani, R, Mahr, A, Matteson, E, Merkel, P, Specks, U, Watts, R